Turn recording back on
Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids.
Miller AL, Komak S, Webb MS, Leiter EH, Thompson EB.
Cancer Cell Int. 2007 Nov 28;7:18.
PMID: 18045478 [PubMed - in process]
Related Articles Free article in PMC
Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD, Saeed MF, Johnson BH, Thompson EB.
Cancer Res. 1998 Aug 15;58(16):3684-93.
PMID: 9721879 [PubMed - indexed for MEDLINE]
Related Articles
Identification of genes leading to glucocorticoid-induced leukemic cell death.
Thompson EB, Webb MS, Miller AL, Fofanov Y, Johnson BH.
Lipids. 2004 Aug;39(8):821-5. Review.
PMID: 15638253 [PubMed - indexed for MEDLINE]
Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.
Thompson EB, Johnson BH.
Recent Prog Horm Res. 2003;58:175-97. Review.
PMID: 12795419 [PubMed - indexed for MEDLINE]
Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S, Hartmann BL, Hala M, Strasser-Wozak EM, Kapelari K, Kofler R.
Cancer Res. 1996 Nov 1;56(21):5033-8.
PMID: 8895760 [PubMed - indexed for MEDLINE]
Gene networks in glucocorticoid-evoked apoptosis of leukemic cells.
Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Thompson EB.
J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):183-93.
PMID: 12943703 [PubMed - indexed for MEDLINE]
Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.
Ashraf J, Kunapuli S, Chilton D, Thompson EB.
J Steroid Biochem Mol Biol. 1991 May;38(5):561-8.
PMID: 2039752 [PubMed - indexed for MEDLINE]
Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
Miller AL, Webb MS, Thompson EB.
Steroids. 2007 Sep;72(9-10):673-81. Epub 2007 May 29.
PMID: 17606285 [PubMed - indexed for MEDLINE]
Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
Medh RD, Wang A, Zhou F, Thompson EB.
Oncogene. 2001 Aug 2;20(34):4629-39.
PMID: 11498786 [PubMed - indexed for MEDLINE]
Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts.
Zhou F, Thompson EB.
Mol Endocrinol. 1996 Mar;10(3):306-16.
PMID: 8833659 [PubMed - indexed for MEDLINE]
Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis.
Medh RD, Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Luxon BA, Thompson EB.
Genomics. 2003 Jun;81(6):543-55.
PMID: 12782123 [PubMed - indexed for MEDLINE]
Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells.
Priceman SJ, Kirzner JD, Nary LJ, Morris D, Shankar DB, Sakamoto KM, Medh RD.
Biochem Biophys Res Commun. 2006 Jun 2;344(2):491-9. Epub 2006 Apr 5.
PMID: 16630563 [PubMed - indexed for MEDLINE]
Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
Thompson EB, Nazareth LV, Thulasi R, Ashraf J, Harbour D, Johnson BH.
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):273-82.
PMID: 1314075 [PubMed - indexed for MEDLINE]
Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
Hala M, Hartmann BL, Böck G, Geley S, Kofler R.
Int J Cancer. 1996 Nov 27;68(5):663-8.
PMID: 8938150 [PubMed - indexed for MEDLINE]
Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells.
Miller AL, Garza AS, Johnson BH, Thompson EB.
Cancer Cell Int. 2007 Mar 28;7:3.
PMID: 17391526 [PubMed]
Low glucocorticoid receptor (GR), high Dig2 and low Bcl-2 expression in double positive thymocytes of BALB/c mice indicates their endogenous glucocorticoid hormone exposure.
Boldizsár F, Pálinkás L, Czömpöly T, Bartis D, Németh P, Berki T.
Immunobiology. 2006;211(10):785-96. Epub 2006 Jul 28.
PMID: 17113916 [PubMed - indexed for MEDLINE]
Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines.
Adebodun F, Post JF.
J Cell Physiol. 1995 Apr;163(1):80-6.
PMID: 7896902 [PubMed - indexed for MEDLINE]
Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: Signaling pathway interactions.
Garza AS, Miller AL, Johnson BH, Thompson EB.
Leuk Res. 2008 Nov 12. [Epub ahead of print]
PMID: 19012965 [PubMed - as supplied by publisher]
Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development.
James CG, Ulici V, Tuckermann J, Underhill TM, Beier F.
BMC Genomics. 2007 Jul 1;8:205.
PMID: 17603917 [PubMed - indexed for MEDLINE]
Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
Ploner C, Schmidt S, Presul E, Renner K, Schröcksnadel K, Rainer J, Riml S, Kofler R.
J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):153-60. Epub 2005 Jan 26.
PMID: 15860257 [PubMed - indexed for MEDLINE]